Study on PAD and CAS Based on Omics and Imaging

Sponsor
Yijie Ning
Study ID
NCT06917547
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Study Details

This study aims to investigate the pathogenesis of Peripheral Artery Disease (PAD) and Carotid Artery Stenosis (CAS) using a comprehensive multi-omics and multi-modal imaging approach. The study will enroll patients diagnosed with PAD or CAS and perform advanced imaging techniques, including NIR-II Imaging, DUS-based V-flow Imaging, and Laser Speckle Imaging, to assess vascular structure and function. Simultaneously, single-cell transcriptomics, metabolomics, lipidomics, and proteomics analyses will be conducted on patient samples to identify key molecular targets and pathways involved in disease progression. Machine learning algorithms will be employed to integrate imaging and multi-omics data, enabling the development of predictive models for more accurate disease diagnosis and stratification. The findings from this study are expected to provide novel insights into the molecular mechanisms underlying PAD and CAS and contribute to the development of personalized therapeutic strategies.

Key Dates

First listed
Apr 8, 2025
Start date
Apr 1, 2025
Status verified
Mar 2025
Primary completion
Oct 1, 2025
Completion
Oct 1, 2025

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Time related NIR-II parameters for CAS and PAD patients [ Time Frame: Baseline, 6 months ]

Central Contacts

Find similar trials

Nationwide
Peripheral artery disease trialsCardiology trialsVascular medicine trials

Related Studies